Open AccessLacosamide: a Study of Exposures Reported to US Poison Centers over a 9-Year Period
Author(s) -
John Teijido,
Derek Kempf,
Elizabeth Laubach,
Amy Zosel,
Douglas J. Borys
Publication year - 2019
Publication title -
journal of medical toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.534
H-Index - 49
eISSN - 1937-6995
pISSN - 1556-9039
DOI - 10.1007/s13181-019-00717-y
Subject(s) - lacosamide , medicine , emergency medicine , poison control , pharmacology , toxicology , medical emergency , psychiatry , epilepsy , biology
Lacosamide (Vimpat®) is an anticonvulsant used to treat partial-onset seizures. Little is known about the characteristics and outcomes of patients exposed to lacosamide.